Zim Laboratories P/B Ratio
Zim Laboratories (ZIMLAB) P/B ratio is 1.61 (Moderate), book value per share ₹51.43 vs Healthcare average P/B of -1.0 — Moderate - Reasonably valued relative to book value. For live price, earnings yield and the full fundamental profile, see ZIMLAB stock price BSE.
Current Valuation Metrics
Book Value Breakdown (2025)
Valuation Signal
Sector Context
ZIMLAB P/B Ratio — Valuation Insights & Book Value Analysis
Zim Laboratories price-to-book ratio interpretation, valuation status and historical context — current P/B 1.61 (Moderate). Check Zim Laboratories market worth to track the company's total market size over time.
- Trading at premium to sector average PB of -1.0
Zim Laboratories P/B Ratio Historical Trend
ZIMLAB annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Also explore ZIMLAB price trends to track price trends across different timeframes.
ZIMLAB Historical P/B Ratio — Book Value Per Share & Year-End Price
Zim Laboratories annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2025 | 1.4 | ₹51.43 | ₹72.15 | ₹252 | Moderate |
| 2024 | 2.2 | ₹48.78 | ₹107.52 | ₹239 | Moderate |
| 2023 | 2.83 | ₹40.82 | ₹115.35 | ₹200 | Moderate |
| 2022 | 0.88 | ₹110.0 | ₹97.20 | ₹176 | Low |
| 2021 | 0.39 | ₹100.62 | ₹39.40 | ₹161 | Low |
ZIMLAB vs Healthcare Peers — P/B Ratio Comparison
Zim Laboratories P/B 1.61 vs Healthcare average -1.0, median 0.62 — range -36.63–1.05.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -36.63 | ₹28 | Low |
| Sun Pharma Advanced Rese… | SPARC | -13.83 | ₹4,744 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.35 | ₹76 | Low |
| Parmax Pharma | PARMAX | -2.09 | ₹12 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.8 | ₹128 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |